Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 43,085 | 32,087 | 38,858 | 36,216 | 44,368 |
| Cost of Goods | 2,591 | 2,844 | 3,907 | 3,906 | 2,937 |
| Gross Profit | 40,494 | 29,243 | 34,951 | 32,310 | 41,431 |
| Operating Expenses | 24,021 | 46,277 | 47,401 | 27,512 | -35,032 |
| Operating Income | 17,064 | -16,190 | -11,543 | 5,704 | 77,400 |
| Interest Expense | 261 | 264 | 263 | 175 | 4,624 |
| Other Income | 1,277 | -89 | -703 | -4,275 | 11,933 |
| Pre-tax Income | 18,080 | -16,543 | -12,509 | 1,254 | 84,709 |
| Income Tax | 13,346 | 3,451 | 7,449 | 7,312 | 9,625 |
| Net Income Continuous | 4,734 | -19,994 | -19,958 | -6,058 | 75,084 |
| Net Income | $4,734 | $-19,994 | $-19,958 | $-6,058 | $75,084 |
| EPS Basic Total Ops | 0.11 | -0.48 | -0.48 | -0.15 | 1.85 |
| EPS Basic Continuous Ops | 0.12 | -0.48 | -0.48 | -0.15 | 1.85 |
| EPS Diluted Total Ops | 0.11 | -0.48 | -0.48 | -0.15 | 1.80 |
| EPS Diluted Continuous Ops | 0.12 | -0.48 | -0.48 | -0.15 | 1.80 |
| EBITDA(a) | $19,998 | $-12,316 | $-7,616 | $9,458 | $80,732 |